Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Synonyms :
Class :
Brand Name :
Synonyms :
Class :
It's an anti-obesity medication. belongs to antagonists of the selective cannabinoid type 1 (CB1) receptor
The main purpose of this drug is to treat obesity
One 20 mg tablet taken one time daily is the standard dosage
Dose Adjustments
Limited data is available
inhibitors of the cytochrome P450 enzyme system, like ketoconazole and clarithromycin, have the potential to enhance the exposure and toxicity of rimonabant since it undergoes liver metabolism mediated by this enzyme system
inhibitors of the cytochrome P450 enzyme system, like ketoconazole and clarithromycin, have the potential to enhance the exposure and toxicity of rimonabant since it undergoes liver metabolism mediated by this enzyme system
inhibitors of the cytochrome P450 enzyme system, like ketoconazole and clarithromycin, have the potential to enhance the exposure and toxicity of rimonabant since it undergoes liver metabolism mediated by this enzyme system
inhibitors of the cytochrome P450 enzyme system, like ketoconazole and clarithromycin, have the potential to enhance the exposure and toxicity of rimonabant since it undergoes liver metabolism mediated by this enzyme system
inhibitors of the cytochrome P450 enzyme system, like ketoconazole and clarithromycin, have the potential to enhance the exposure and toxicity of rimonabant since it undergoes liver metabolism mediated by this enzyme system
rimonabant has the potential to intensify the effects of additional central nervous system depressants, including alcohol, benzodiazepines, and opioids, resulting in heightened sedation or respiratory depression
rimonabant has the potential to intensify the effects of additional central nervous system depressants, including alcohol, benzodiazepines, and opioids, resulting in heightened sedation or respiratory depression
rimonabant has the potential to intensify the effects of additional central nervous system depressants, including alcohol, benzodiazepines, and opioids, resulting in heightened sedation or respiratory depression
rimonabant has the potential to intensify the effects of additional central nervous system depressants, including alcohol, benzodiazepines, and opioids, resulting in heightened sedation or respiratory depression
rimonabant has the potential to intensify the effects of additional central nervous system depressants, including alcohol, benzodiazepines, and opioids, resulting in heightened sedation or respiratory depression
inducing agents of the cytochrome P450 enzymes, such as rifampin and carbamazepine, can reduce the exposure and effectiveness of rimonabant
inducing agents of the cytochrome P450 enzymes, such as rifampin and carbamazepine, can reduce the exposure and effectiveness of rimonabant
inducing agents of the cytochrome P450 enzymes, such as rifampin and carbamazepine, can reduce the exposure and effectiveness of rimonabant
inducing agents of the cytochrome P450 enzymes, such as rifampin and carbamazepine, can reduce the exposure and effectiveness of rimonabant
the risk of adverse effects may be elevated when rimonabant is combined with trifluoperazine
combining trihexyphenidyl with rimonabant may heighten the risk of tachycardia and drowsiness
when combined with rimonabant, there is an increased risk of adverse effects
the combination of rimonabant with triflupromazine increases the risk of adverse effects
the use of trimebutine in combination with rimonabant increases the risk or severity of tachycardia and drowsiness
the risk of adverse effects may be heightened when trimethadione is combined with rimonabant
combining trimethobenzamide with rimonabant increases the risk of adverse effects
the risk of adverse effects may be elevated when rimonabant is combined with trimipramine
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
